Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fludarabine and cyclophosphamide, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Thalidomide may stop the growth of lymphoma by blocking blood flow to the
cancer. Giving fludarabine and cyclophosphamide together with thalidomide may kill more
cancer cells.
PURPOSE: This phase II trial is studying how well giving fludarabine and cyclophosphamide
together with thalidomide works in treating patients with angioimmunoblastic T-cell lymphoma.